Covered recipient · General Payments record
DURGA MAINALY
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Acute Care
General Payments · PY2024
$428.09
- Reported across 15 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $428.09 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| SK Life Science, Inc. | $164.31 | 3 |
| UCB, Inc. | $59.13 | 2 |
| Aucta Pharmaceuticals, Inc. | $56.87 | 3 |
| Genentech USA, Inc. | $50.95 | 2 |
| EISAI INC. | $21.01 | 1 |
| Amgen Inc. | $20.75 | 1 |
| Neurocrine BioSciences, Inc. | $20.73 | 1 |
| Neurelis, Inc. | $18.75 | 1 |
| ARGENX US, INC. | $15.59 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2024 | $428.09 | 15 |
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $20.75 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115893382 | CMS |
| ARGENX US, INC. | $15.59 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142144847 | CMS |
| Aucta Pharmaceuticals, Inc. | $21.10 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147904828 | CMS |
| Aucta Pharmaceuticals, Inc. | $8.17 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147905060 | CMS |
| Aucta Pharmaceuticals, Inc. | $27.60 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147905346 | CMS |
| Eisai Inc. | $21.01 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110800349 | CMS |
| Genentech USA, Inc. | $27.13 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133155859 | CMS |
| Genentech USA, Inc. | $23.82 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133155855 | CMS |
| Neurelis, Inc. | $18.75 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145666843 | CMS |
| Neurocrine Biosciences, Inc. | $20.73 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150976073 | CMS |
| SK Life Science, Inc. | $29.48 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154134918 | CMS |
| SK Life Science, Inc. | $9.84 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154134962 | CMS |
| SK Life Science, Inc. | $124.99 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154135030 | CMS |
| UCB, Inc. | $34.50 | 03/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143082527 | CMS |
| UCB, Inc. | $24.63 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143082529 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2024
- Source files
- Dataset page · Bulk file · PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.